MyGenome, the genomics subsidiary of Alps Group Inc., has extended its MS ISO 15189:2022 laboratory accreditation to cover whole genome sequencing (WGS), positioning it among a limited cohort of Southeast Asian facilities operating WGS workflows under internationally recognized clinical quality standards. The milestone carries direct implications for the functional-nutrition and personalized-supplement sectors, where genomic data is increasingly used to inform product recommendations, dosing protocols, and structure-function claims.
ISO 15189 is the globally accepted benchmark for medical laboratory quality and competence. Its extension to WGS within MyGenome's facility means that genomic data underpinning nutrigenomic panels — covering areas such as micronutrient metabolism, lipid response, and caffeine clearance — is now generated under a validated, auditable framework. For finished-formulation developers and white-label supplement brands that license genomic insights to drive personalized product lines, third-party accreditation of this caliber reduces liability exposure and strengthens the evidentiary basis for any associated structure-function claims.
The personalized nutrition market in Asia-Pacific has expanded rapidly, driven by consumer demand for precision health solutions and the proliferation of direct-to-consumer genomic testing kits. WGS offers substantially deeper resolution than targeted SNP panels, enabling more granular assessment of gene variants linked to vitamin D receptor sensitivity, omega-3 metabolism, and gut-microbiome predispositions — all clinically relevant endpoints for functional food and nutraceutical formulators. Operators building personalized supplement platforms or genomics-informed product lines now have access to a regionally accredited WGS data source that can support more defensible health positioning.
The accreditation also reflects a broader tightening of quality expectations across the nutrigenomic testing supply chain. Regulatory bodies in markets including Malaysia, Singapore, and Thailand have signaled increased scrutiny of laboratory-generated health claims, particularly where genomic data is used to recommend specific ingredients, doses, or finished formulations. MyGenome's ISO 15189 standing aligns its WGS output with the documentation standards increasingly required by both regulators and institutional buyers. Brands sourcing genomic insights for clinical-validation strategies in functional foods will find accredited WGS data a stronger foundation than consumer-grade panel alternatives.
Alps Group has not disclosed revenue figures or testing volume metrics associated with the WGS expansion. Industry observers note, however, that demand for clinically validated genomic services within functional nutrition is outpacing supply of accredited regional providers — a gap MyGenome's certification begins to address.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.